Dr. Falk Pharma GmbH

Poland

All drugs from this manufacturer

  • BUDENOFALK

    The medicine is used to treat active ulcerative colitis limited to the rectum and sigmoid colon.

    Dosage form: foam for rectal use

    Active substance Dosage
    budesonide 2 mg/dose; 48 mg/pen

    ATC: A07EA06

  • MUCOFALK O

    The medicine is used for the treatment of habitual constipation and in situations where soft stools are desired to facilitate bowel movements (e.g., after anal surgery, in case of hemorrhoids or anal fissures). It also helps to increase dietary fiber intake, e.g., in irritable bowel syndrome or as support for high cholesterol levels.

    Dosage form: powder for preparation of oral suspension

    Active substance Dosage
    plantago ovata seed coat 3.25 g

    ATC: A06A

  • SALOFALK

    The medicine is used to treat acute flares of ulcerative colitis. It acts locally as an anti-inflammatory on the mucosa and tissue of the large intestine.

    Dosage form: suspension, rectal

    Active substance Dosage
    mesalazine 4 mg

    ATC: A07EC02

  • SALOFALK

    The medicinal product is used for the treatment of acute episodes and the prevention of relapses of mild to moderate ulcerative colitis and inflammatory bowel disease (colitis).

    Dosage form: granules, extended release for oral use

    Active substance Dosage
    mesalazine 1.5 g

    ATC: A07EC02

  • SALOFALK

    Salofalk is used for the treatment of acute episodes and the prevention of relapses of mild to moderate ulcerative colitis and inflammatory bowel disease (colitis).

    Dosage form: granules, extended release for oral use

    Active substance Dosage
    mesalazine 3 g

    ATC: A07EC02

  • SALOFALK

    The medicine is used for the treatment of acute episodes and the prevention of relapses of mild to moderate ulcerative colitis and inflammatory bowel disease (colitis).

    Dosage form: granules, extended release for oral use

    Active substance Dosage
    mesalazine 1000 mg

    ATC: A07EC02

  • SALOFALK 1 G

    The medicine is used to treat acute episodes of mild to moderate ulcerative colitis or proctitis limited to the rectum.

    Dosage form: suppositories

    Active substance Dosage
    mesalazine 1000 mg

    ATC: A07EC02

  • SALOFALK 500

    The medicine is used in the treatment of ulcerative colitis (during flare-ups and to prevent relapses) and in Crohn's disease (during flare-ups).

    Dosage form: tablets, enteric-coated

    Active substance Dosage
    mesalazine 500 mg

    ATC: A07EC02

  • SALOFALK 500

    The medicine is used during the flare-up phase of ulcerative proctitis.

    Dosage form: suppositories

    Active substance Dosage
    mesalazine 500 mg

    ATC: A07EC02

  • URSOFALK

    The medicine is used to dissolve cholesterol gallstones in the gallbladder (in patients for whom surgery is not possible), for the symptomatic treatment of primary biliary cholangitis, and for the treatment of liver disorders in children with cystic fibrosis.

    Dosage form: capsules

    Active substance Dosage
    ursodeoxycholic acid 250 mg

    ATC: A05AA02

  • URSOFALK

    The medicine is used to dissolve cholesterol gallstones in the gallbladder (in patients who cannot undergo surgery), in the treatment of primary biliary cholangitis, and in the case of liver disorders in children with cystic fibrosis.

    Dosage form: suspension, oral

    Active substance Dosage
    ursodeoxycholic acid 250 mg/5 ml

    ATC: A05AA02

  • URSOFALK

    The medicine is used to dissolve cholesterol gallstones in the gallbladder (in patients who cannot undergo surgery), in the treatment of primary biliary cholangitis, and in the treatment of liver disorders in children (aged 6–18 years) due to cystic fibrosis.

    Dosage form: tablets, film-coated

    Active substance Dosage
    ursodeoxycholic acid 500 mg

    ATC: A05AA02